AB21-5
T. Vogtmann, Joachim C. Will(Charité - Universitätsmedizin Berlin), Ellen B. Roll(Charité - Universitätsmedizin Berlin), Heinz Theres(Charité - Universitätsmedizin Berlin), Bernd Opgen‐Rhein(Charité - Universitätsmedizin Berlin), Gregor Krings(Cleveland Clinic)
Cited by 1
Related Papers
Comprehensive analysis of normal adjacent to tumor transcriptomes
|Nature Communications|2017|663
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
|Nature Medicine|2016|539
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
|Circulation|2008|454
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
|Nature Medicine|2018|292
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
|Oncotarget|2017|180